MURALI D. SHARATH, MD, FACP
ALLERGY AND ASTHMA CENTER
4532 Bonney Road, Suite C
Virginia Beach, VA 23462
Phone: 757-499-4101 • Fax: 757-497-2419


PRESENT POSITION: DIRECTOR

EXPERTISE IN:

Treatment of allergic diseases, asthma and related immunological diseases.

Organizing and implementing policies and guidelines for the management of common allergic disorders [Allergy Clinic, Norfolk General Hospital].

Teaching residents and medical students of Eastern Virginia Medical School, Norfolk, Virginia.

Medical and administrative supervision of Occupational and Preventive Health Services [Federal Clinic, Norfolk, Virginia].

QUALIFICATIONS:

Fellow of the American College of Physicians [FACP], 1985

Board Certified in Internal Medicine by the American Board of Internal Medicine [ABIM], 1984

Board eligible for certification by the American Board of Allergy, Asthma and Immunology, 1984

Diplomate in Aviation Medicine [AMD], Banglore University, India, 1972

Bachelor of Medicine and Bachelor of Surgery [MBBS], Banglore University, India, 1970

RESEARCH AND TEACHING:

Fellow in allergy and immunology, instructor in medicine

University of Iowa Hospitals and Clinics, Iowa City, Iowa, 1981-1984

Chief resident in and instructor of Internal Medicine, Eastern Virginia Medical School, Norfolk, Virginia, 1980-1981

Resident in Internal Medicine, Eastern Virginia Medical School, Norfolk, Virginia, 1987-1980

Resident in Internal Medicine, VA Hospital, Wright State University, Dayton, Ohio, 1977-1978

Resident in Medicine, National Health Service, England, United Kingdom, 1973-1977

Resident in Aviation Medicine, Institute Of Aviation Medicine, Banglore, India, 1971-1972

Resident in Medicine, Government General Hospital, Madras Universite, India, 1970-1971

Tutor in Pathology, Tanjore Medical College and Hospital, Madras, India, 1969-1970

Rotating intern, Kilpauk Medical College, Madras University, India, 1968-1969

MEMBERSHIPS:

American College of Physicians
American Academy of Allergy, Asthma & Immunology
American College of Allergy, Asthma & Immunology
Virginia Allergy & Asthma Society

PUBLICATIONS:

Sharath Murali Dharan C., Balakrishnan S., Baker JP: "Right Bundle Branch Block Preceding Clinical Pulmonary Embolism." Virginia Medical, 107:133, 1980.

Weiler JM, Sharath MD, Donnelly A, Metzger WJ, Richerson HB, Medsker RD, Halverson PC, Packard BD, Kregel KC, Crowley ET: "Prevalence of Bronchial Hyper-responsiveness within a Universite Foot-ball Team." J. Allergy Clin Immunol, 71:108,1983.

Shareth MD, Rinderknecht SB, Weiler JM: "Immunoglobulin Production by Human PBL in Serum-Free Medium." Federation Proceedings, 42: 411, 1983.

Sharath MD, Rinderknecht SB, Weiler JM: "Human Immunoglobulin Biosynthesis in a Serum-Free Medium." J. Lab Clin Med. 102: 739-43, 1984.

Metzger WJ, Grem J, Halverson PC, Sharath MD, Shulan DJ, Lawton W, Weiler JM: "CIINH Deficiency and Angioedema: A Spectrum of Disease." Annals of Allergy, 52: 269-90, 1984.

Weiler JM, Freiman P, Sharath MD, Metzger WJ, Smith JM, Richerson HB, Ballas ZK, Halverson PC, Shulan DJ, Matsuo S, Wilson RL: "Serious Adverse Reactions to Protamine Sulfate: Are Alternatives Needed?" J. Allergy Clin Immunol, 75: 297-303, 1985

Linhardt RJ, Sharath MD, Merchant ZM, Kim YS, Rice KG, Weiler JM: "Small Heparin Fragments Inhibit Complement Activation." Federation Proceedings, 44: 989, 1985.

Sharath MD, Merchant ZM, Kim YS, Linhardt RJ, Weiler JM: "Role of Heparin Size and Structure in the Regulation of the Amplification Pathway of Complement." J. Immuno Pharmacol, 9: 73-80, 1985.

Sharath MD, Metzger WJ, Richarson HB, Scupham RK, Ginsburg BH, Meng RL, Weiler JM: "Protamine Induced Fatal Anaphylaxis: Prevalence of Anti-Protamine Immunoglobulin E Antibody." J Thorac Cardiovasc Surg, 90: 86-90, 1985.

Weiler JM, Rinderknecht SB, Sharath MD, Yarchoan R: "Human Secondary Immune Response Induced by Influenza in a Serum-Free Culture System." J. Immunological Methods: 82, No:2, 333-39, 1985

Eeiler JM, Metzger WJ, Donnelly AL, Crowley ET, Sharath MD: "Prevalence of Bronchial Hyperresponsiveness in Highly-Trained Athletes." Chest, 90: 23-28, 1986.

CLINICAL INVESTIGATIONS:

Flunisolide Nasal Spray Trials: August-October, 1981
Azelastine Drug Trials: May-June and August, 1983; May-June and August, 1984.

INVENTIONS AND PATENTS:

Low Molecular Weight Heparin Fragments as Inhibitors of Complement Activation. Patent No; 4847338, Date of Patent: 07-11-1989

ONGOING INTERESTS:

Asthma
Drug Reactions





   Home Page    About Us    Allergic Nose    Asthma 101    Sting Reactions


This site is best viewed with Macromedia Flash.
Click here to view site without Flash.




Site Manager Sign In

Powered by
Yellow Pages
Yellow Pages